Did you know that there are fewer human cells in our body than bacterial cells? For the human body to contain anything other than our own cells has always caused controversy; however, the idea of a second genome has been around for a while. Continue reading What is the Second Genome and how does it affect us?
For some SynBio UK was their first experience of a face-to-face academic conference. For others, it was the first chance to catch up with colleagues from around the country after almost two years of separation. For everybody, it was a fantastic opportunity to hear about the exciting fundamental and applied research in Synthetic Biology happening across the UK and beyond! Continue reading A long-awaited return to in-person conferences – Synthetic Biology UK 2021
On the 4th October 2021 Biochemical Society awarded a Sponsored Event Grant to Dr Caroline McKinnon at the University of Bristol for a project to recognise and celebrate the legacy of Henrietta Lacks. Continue reading Unveiling of the Henrietta Lacks statue
Short Interfering RNA (siRNA) has come of age to unleash its full potential as a potent therapeutic. The onset of a series of FDA approvals of the siRNA medication targeting rare, previously untreatable genetic disorders and several other promising drug candidates in clinical trials have established the RNA Interference (RNAi) technology in the therapeutic realms. Designing a highly effective siRNA is one of the critical challenges of its downstream usage as a potential drug. Continue reading Designing therapeutic siRNAs
If science is the most communal of human endeavors, drug discovery is its pinnacle. Over the course of decades, many people work together in a cyclical process of design, create and test. They’re brought together with the shared goal: producing a single molecule, a new drug, which will improve the lives of those suffering from disease. Continue reading From Seed to Root – The WeeCAIR Medicinal Garden